Molecular epidemiology of Plasmodium vivax anti-folate resistance in India

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Prajapati, Surendra K ^a   Joshi, Hema ^a   Dev, Vas ^b   Dua, Virendra K ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b NIMR Field Station   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FOLIC ACID ANTAGONIST; ANTIMALARIAL AGENT; PROTOZOAL DNA; PROTOZOAL PROTEIN; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; INDIA; MICROSCOPY; MOLECULAR EPIDEMIOLOGY; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTOZOAL GENETICS; SEQUENCE ANALYSIS; TANDEM REPEAT; WILD TYPE; AMINO ACID SUBSTITUTION; DNA SEQUENCE; DRUG COMBINATION; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALARIA; MISSENSE MUTATION; MOLECULAR GENETICS; PARASITOLOGY; PHYLOGENY; PHYLOGEOGRAPHY;

AMINO ACID SUBSTITUTION; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DNA, PROTOZOAN; DRUG COMBINATIONS; FOLIC ACID ANTAGONISTS; GENOTYPE; HUMANS; INDIA; MALARIA; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; PHYLOGEOGRAPHY; PLASMODIUM VIVAX; POINT MUTATION; PROTOZOAN PROTEINS; PYRIMETHAMINE; SEQUENCE ANALYSIS, DNA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 79955017844     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-102     Document Type: Article

References (44)

1. Annual Report. WHO, World Health Organization Geneva 2008
2. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. BB Andrade A Reis-Filho SM Souza-Neto J Clarencio LM Camargo A Barral M Barral-Netto, Malar J 2010 9 13 10.1186/1475-2875-9-13 20070895
3. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. DK Kochar A Das SK Kochar V Saxena P Sirohi S Garg A Kochar MP Khatri V Gupta, Am J Trop Med Hyg 2009 80 194 198 19190212
4. Plasmodium vivax malaria. DK Kochar V Saxena N Singh SK Kochar SV Kumar A Das, Emerg Infect Dis 2005 11 132 134 15705338 (Pubitemid 40093368)
5. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. B Genton V D'Acremont L Rare K Baea JC Reeder MP Alpers I Muller, PLoS Med 2008 5 127 10.1371/journal.pmed.0050127 18563961
6. Severe vivax malaria: newly recognised or rediscovered. SJ Rogerson R Carter, PLoS Med 2008 5 136 10.1371/journal.pmed.0050136 18563965
7. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. E Tjitra NM Anstey P Sugiarto N Warikar E Kenangalem M Karyana DA Lampah RN Price, PLoS Med 2008 5 128 10.1371/journal.pmed.0050128 18563962
8. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. JD Chulay WM Watkins DG Sixsmith, Am J Trop Med Hyg 1984 33 325 330 6375404 (Pubitemid 14075628)
9. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. AF Cowman MJ Morry BA Biggs GA Cross SJ Foote, Proc Natl Acad Sci USA 1988 85 9109 9113 10.1073/pnas.85.23.9109 3057499 (Pubitemid 19001849)
10. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. T Triglia JG Menting C Wilson AF Cowman, Proc Natl Acad Sci USA 1997 94 13944 13949 10.1073/pnas.94.25.13944 9391132 (Pubitemid 28009689)
11. Resistance to chloroquine in falciparum malaria in Assam state, India. PN Sehgal MID Sharma SS I S Gogal, J Commun Dis 1973 5 175 180
12. National Vector Borne Disease Control Programme. http://www.nvbdcp.gov.in
13. Plasmodium vivax resistance to chloroquine? KH Rieckmann DR Davis DC Hutton, Lancet 1989 2 1183 1184 2572903 (Pubitemid 19275451)
14. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. PL Garavelli E Corti, Trans R Soc Trop Med Hyg 1992 86 128 10.1016/0035-9203(92) 90535-K 1440766
15. Vivax malaria resistant to chloroquine: case reports from Bombay. M Garg N Gopinathan P Bodhe NA Kshirsagar, Trans R Soc Trop Med Hyg 1995 89 656 657 10.1016/0035-9203(95)90432-8 8594687 (Pubitemid 26016354)
16. Vivax malaria resistant to treatment and prophylaxis with chloroquine. GS Murphy H Basri Purnomo EM Andersen MJ Bangs DL Mount J Gorden AA Lal AR Purwokusumo S Harjosuwarno,, et al. Lancet 1993 341 96 100 10.1016/0140-6736(93) 92568-E 8093414 (Pubitemid 23028126)
17. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). K Myat Phone O Myint L Myint Z Thaw A Kyin Hla Y Nwe Nwe, Trans R Soc Trop Med Hyg 1993 87 687 10.1016/0035-9203(93)90294-Z 8296378
18. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. GJ Schuurkamp PE Spicer RK Kereu PK Bulungol KH Rieckmann, Trans R Soc Trop Med Hyg 1992 86 121 122 10.1016/0035-9203(92)90531-G 1440763
19. Chloroquine-resistant Plasmodium vivax from Indonesia. IK Schwartz EM Lackritz LC Patchen, N Engl J Med 1991 324 927 2000122
20. In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax. AR Hasugian E Tjitra A Ratcliff H Siswantoro E Kenangalem RM Wuwung HL Purba KA Piera F Chalfien J Marfurt PM Penttinen B Russell NM Anstey RN Price, Antimicrob Agents Chemother 2009 53 1094 1099 10.1128/AAC.01511-08 19104023
21. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. B Russell F Chalfein B Prasetyorini E Kenangalem K Piera R Suwanarusk A Brockman P Prayoga P Sugiarto Q Cheng E Tjitra NM Anstey RN Price, Antimicrob Agents Chemother 2008 52 1040 1045 10.1128/AAC.01334-07 18180357 (Pubitemid 351358386)
22. Burden of malaria in India: retrospective and prospective view. A Kumar N Valecha T Jain AP Dash, Am J Trop Med Hyg 2007 77 69 78 18165477
23. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. MT Alam H Bora PK Bharti MA Saifi MK Das V Dev A Kumar N Singh AP Dash B Das Wajihullah YD Sharma, Antimicrob Agents Chemother 2007 51 857 863 10.1128/AAC.01200-06 17194833 (Pubitemid 46355267)
24. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. S Kaur SK Prajapati K Kalyanaraman A Mohmmed H Joshi VS Chauhan, Acta Trop 2006 97 174 180 10.1016/j.actatropica.2005.10.003 16310156 (Pubitemid 43087751)
25. Allelic polymorphism in the Plasmodium vivax dihydrofolate reductase gene among Indian field isolates. SK Prajapati H Joshi N Valecha AM Reetha A Eapen A Kumar MK Das RS Yadav MA Rizvi AP Dash, Clin Microbiol Infect 2007 13 331 334 10.1111/j.1469-0691.2006.01639.x 17391393 (Pubitemid 46603369)
26. Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent. SK Prajapati A Verma T Adak RS Yadav A Kumar A Eapen MK Das N Singh SK Sharma MA Rizvi AP Dash H Joshi, Malar J 2006 5 90 10.1186/1475-2875-5-90 17062127
27. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. M Imwong S Pukrittakayamee S Looareesuwan G Pasvol J Poirreiz NJ White G Snounou, Antimicrob Agents Chemother 2001 45 3122 3127 10.1128/AAC.45.11.3122-3127.2001 11600366 (Pubitemid 32988838)
28. Genetic variations of the Plasmodium vivax dihydropteroate synthase gene. M Menegon G Majori C Severini, Acta Trop 2006 98 196 199 10.1016/j.actatropica. 2006.03.003 16647679 (Pubitemid 43783138)
29. Korea. Macrogen Inc, http://www.macrogen.com
30. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. N Valecha H Joshi A Eapen J Ravinderan A Kumar SK Prajapati P Ringwald, Trans R Soc Trop Med Hyg 2006 100 831 837 10.1016/j.trstmh.2005.11.012 16513151 (Pubitemid 43986288)
31. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India. A Nandy M Addy AK Maji AK Bandyopadhyay, Ann Trop Med Parasitol 2003 97 215 220 10.1179/000349803235001868 12803853 (Pubitemid 36606354)
32. Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children. T Jelinek AH Kilian J Curtis MT Duraisingh G Kabagambe F von Sonnenburg DC Warhurst, Am J Trop Med Hyg 1999 61 125 130 10432069 (Pubitemid 29345001)
33. In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. SM Kiara J Okombo V Masseno L Mwai I Ochola S Borrmann A Nzila, Antimicrob Agents Chemother 2009 53 3793 3798 10.1128/AAC.00308-09 19528269
34. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India. N Raizada LS Chauhan BS Babu R Thakur A Khera DF Wares S Sahu D Bachani BB Rewari PK Dewan, PLoS One 2009 4 5999 10.1371/journal.pone.0005999 19543396
35. Decrease Use of Cotrimoxazole in Clinical Practice: Is it Justified? V Bansa V Jose B Medhi P Pandhi, JK SCIENCE 2010 12 214 215
36. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. MD Hastings JD Maguire MJ Bangs PA Zimmerman JC Reeder JK Baird CH Sibley, Antimicrob Agents Chemother 2005 49 733 740 10.1128/AAC.49.2.733-740.2005 15673758 (Pubitemid 40175687)
37. Antifolates can have a role in the treatment of Plasmodium vivax. VN Hawkins H Joshi K Rungsihirunrat K Na-Bangchang CH Sibley, Trends Parasitol 2007 23 213 222 10.1016/j.pt.2007.03.002 17368986 (Pubitemid 46621225)
38. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. M Imwong S Pukrittayakamee L Renia F Letourneur JP Charlieu U Leartsakulpanich S Looareesuwan NJ White G Snounou, Antimicrob Agents Chemother 2003 47 1514 1521 10.1128/AAC.47.5.1514-1521.2003 12709316 (Pubitemid 36548531)
39. Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. BK Na HW Lee SU Moon TS In K Lin M Maung GT Chung JK Lee TS Kim Y Kong, Parasitol Res 2005 96 321 325 10.1007/s00436-005- 1364-0 15924223 (Pubitemid 40941823)
40. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. FP Mockenhaupt J Teun Bousema TA Eggelte J Schreiber S Ehrhardt N Wassilew RN Otchwemah RW Sauerwein U Bienzle, Trop Med Int Health 2005 10 901 908 10.1111/j.1365-3156.2005.01471.x 16135198 (Pubitemid 41291231)
41. Plasmodium falciparum malaria in Nigerian children during high and low transmission seasons: gametocyte carriage and response to oral chloroquine. AA Adedeji FA Fehintola BA Fateye TC Happi AO Amoo GO Gbotosho A Sowunmi, J Trop Pediatr 2005 51 288 294 10.1093/tropej/fmi016 15980028 (Pubitemid 41487865)
42. Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated, Plasmodium falciparum malaria. A Sowunmi BA Fateye AA Adedeji FA Fehintola GO Gbotosho TC Happi AM Oduola, Ann Trop Med Parasitol 2005 99 331 338 10.1179/136485905X36226 15949180 (Pubitemid 40874252)
43. Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. E Tjitra S Suprianto NM Anstey, Trans R Soc Trop Med Hyg 2002 96 434 437 10.1016/S0035-9203(02)90385-8 12497983 (Pubitemid 37362032)
44. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. F Lu CS Lim DH Nam K Kim K Lin TS Kim HW Lee JH Chen Y Wang J Sattabongkot ET Han, Am J Trop Med Hyg 2010 83 474 479 10.4269/ajtmh.2010.10-0004 20810806